Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins - Test2 - elhamkhani - TriplyDB

Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins

Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins

http://www.wikidata.org/entity/Q34657013

about

Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).Molecular diversity through RNA editing: a balancing act.Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.Substitutional A-to-I RNA editing.Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus Passage of a Sendai virus recombinant in embryonated chicken eggs leads to markedly rapid accumulation of U-to-C transitions in a limited region of the viral genome Adenosine deaminases acting on RNA, RNA editing, and interferon action.Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa.Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.ADAR1 Facilitates HIV-1 Replication in Primary CD4+ T Cells Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.ADARs: viruses and innate immunity.ADAR1 restricts LINE-1 retrotransposition.ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication.Variation of HIV-1 mutation spectra among cell types.Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses.Role of Innate Genes in HIV Replication.ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication ADAR1 is a novel multi targeted anti-HIV-1 cellular protein.Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity.Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

P2860

Q24320104-F426C393-E877-406F-9800-1329C6844EAC Q27001020-673C3A5E-182F-4C2F-950E-64E6801F2A1B Q28078188-744D4316-B0A4-493A-9815-32952DDC9BCC Q28235509-86369561-797F-4215-8AA2-4CDDAE94E3CB Q28256487-7EF3E1E4-18D6-4AB1-811A-DD35D3776A27 Q28302608-77BB997E-4BAB-4160-A591-6264428D6D52 Q28660378-B754A4A1-7EE0-4C49-8358-478BC824C3A7 Q33714407-61864275-3735-402E-B59F-94436032858D Q33833030-7CAAB0C0-AB2D-4E78-9D25-F26E544E0F74 Q34057801-9544D99A-9EE7-413C-A236-39C151857B5C Q34208420-AE59E708-E519-40FB-87DC-4E0EB3C962B6 Q34289666-4C2B2953-0589-48B3-A0D1-01AA7EAA8968 Q34481984-10512D17-74E1-4705-BEE6-E1612C666C91 Q34490804-AEF3D186-B4B6-4B8F-9778-70091D1B6C1A Q34553883-2614F58C-534D-4BE6-8F25-F43A4240F40B Q35176322-62FC199A-B40C-4CBF-A042-E842D2470C05 Q35826798-35AD58E7-3C7A-47E9-B5AC-41B53CC51096 Q35858559-C104DB10-B642-4DFC-8E16-D511EED2AA7D Q36364322-F2FF42EA-ED7A-4609-A6DF-C7F161F34ABE Q36371387-D6E84007-2BEC-420C-A6DF-078B85CA5963 Q36728526-68350F91-2D0A-45D9-9301-4DD93375A5F6 Q36807121-879693B6-1B27-4CD1-86B4-1CEA36B1C21B Q37401773-F3F31360-522D-4A84-8019-CC499039B8BF Q37577431-5276F071-7C3F-4B9F-83E8-576714F1724A Q37891173-1B6F41FC-0321-4435-8C84-6199928FF891 Q39097882-4464FDD1-66EC-4346-AFE3-4A7975569B37 Q39187116-EDB0341A-FAB9-4B09-BB31-4CD2D49CD27B Q39375909-9DE6F4E1-9FBD-46E2-80B7-4E8CF4B1419F Q39419975-BDE7D603-F3C7-4571-A428-581CF40A2831 Q39824954-F3EE9809-E8B7-4BF3-ABC6-CB01611D0B4F Q40219824-AEF5401D-8D9D-45D4-B816-6D6C4A49084A Q41135468-A7001189-254A-41DD-A35A-88F35EBA2DDC Q41666767-020563BB-5175-4CD9-B53C-08C74A5BB925 Q42026451-CE9CBCBB-AD56-4CE4-A94D-8C28406BDBAD

P2860

Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins

http://www.wikidata.org/entity/Q34657013

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@ast

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@en

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@nl

type

label

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@ast

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@en

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@nl

prefLabel

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@ast

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@en

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@nl

P1433

Q34657013-456D62E1-D5D7-4F90-9B3F-57A43D6E3E01

P1476

Q34657013-52CB8C23-968F-4C4D-8070-DC0A0EC76409

P2093

Q34657013-5ACD38DB-0186-45BF-B889-FEA6701C6BE5

Q34657013-D6F75C68-A1F7-4D65-A2A4-F4EF85FFDE26

Q34657013-E2CC8CCE-9BE5-4352-9905-6DC0B33EE242

Q34657013-ED417FE4-B40E-45F3-B026-98FFD05BFA7B

Q34657013-FBBE270B-E6A6-444A-8B5D-161B10DBD460

P2860

Q34657013-0E3427AC-D936-42E3-8D29-2C0C1A37E99B

Q34657013-112BE683-7409-401B-9A26-080C9E1DB62E

Q34657013-2560B6ED-233B-4899-9639-ECEE9D591E21

Q34657013-27B02262-59C6-4908-8895-F0785A29AF34

Q34657013-2AB4CDCA-7A9C-4B4B-A005-13AFDAA2C26C

Q34657013-3771303D-2457-4BEA-A768-A028B2D02153

Q34657013-39011474-8800-41B7-A8BA-8067328F1E5A

Q34657013-390C69C1-5761-45C2-8BC5-D1ECB50DB4B0

Q34657013-4017BDF9-BF6B-4CD2-9DA4-448FE625205A

Q34657013-49BDF42D-87B1-4C9A-848F-B83D444B9C41

P304

Q34657013-5E14DF1E-8E81-4E9A-B596-17E35C97CA6F

P31

Q34657013-104003C3-A223-4946-AAA6-DD0FEAF46D00

P356

Q34657013-7625552E-F439-47E6-AECF-0DEDB3940A18

P407

Q34657013-BAE3105C-12D0-42AF-AE6C-DACB939D963A

P433

Q34657013-778DB571-6D62-4274-A3AB-AC7B29F49E10

P478

Q34657013-05F7BAAD-AA95-4E19-9007-86A528A81EB9

P50

Q34657013-E104ED2E-C182-4932-8217-0ED2C376ABE6

P577

Q34657013-A94BBA33-FD84-4187-A1D6-AE36B8A87DA5

P698

Q34657013-ED40BD8B-5FCB-40E9-8BA7-A08C0A8C32EF

P932

Q34657013-729BEC5A-A133-48B2-9961-3A8B5DC4C57F

P356

P1433

Journal of Virology

P1476

Double-stranded RNA adenosine ...... ficiency virus type 1 proteins

@en

P2093

Angsana Phuphuakrat

http://www.w3.org/2001/XMLSchema#string

Chompunuch Boonarkart

http://www.w3.org/2001/XMLSchema#string

Darat Lauhakirti

http://www.w3.org/2001/XMLSchema#string

Romchat Kraiwong

http://www.w3.org/2001/XMLSchema#string

Tun-Hou Lee

http://www.w3.org/2001/XMLSchema#string

P2860

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase

Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.

The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1

The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

DNA deamination mediates innate immunity to retroviral infection

Functional variability of Rev response element in HIV-1 primary isolates

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

P304

10864-10872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00238-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Prasert Auewarakul

P577

2008-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18753201

http://www.w3.org/2001/XMLSchema#string

P932

2573204

http://www.w3.org/2001/XMLSchema#string